Selected Grants
Duke-NCCU Interdisciplinary Postdoctoral Training Program in Child Psychiatric and Neurodevelopmental Conditions Program (DN-IPT)
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2024 - 2029Duke University Psychiatry Physician-Scientist Residency Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029Regulation of notochord vacuole biogenesis: investigating its role in spine formation and IVD Biology
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2028MECHANISTIC INSIGHTS INTO LSD ACTIONS AT 5-HT2A-SEROTONIN RECEPTORS
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2018 - 2028Microglia-Amyloid interactions in delirium superimposed on dementia
ResearchCo Investigator · Awarded by National Institute on Aging · 2017 - 2027DART.3-Revolutionizing Neuropsychiatric Treatment through Noninvasive, Programmable Cell-Type-Specific Neuropharmacology
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2027Exploring synthetic lethality with a novel very high energy electron FLASH radiation beam
ResearchCollaborator · Awarded by National Institutes of Health · 2024 - 2026Duke Testing Site for Stroke Preclinical Assessment Network
ResearchCo Investigator · Awarded by National Institute of Neurological Disorders and Stroke · 2023 - 2025Development of Adrb3 Antagonists for the Treatment of Pain
ResearchCo Investigator · Awarded by National Institutes of Health · 2023 - 2025Immunovascular interactions in postoperative delirium superimposed on dementia (DSD).
ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2025Behavior and Physiology in Aging
Inst. Training Prgm or CMEMentor · Awarded by National Institute on Aging · 2015 - 2025Interrogating the cholinergic basis of opioid reinforcement with subcellular precision
ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2025Phase 2 - Biased Agonists as Rapidly Acting Neuropsychiatric Drugs
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2020 - 2025Peripherally-targeted Adrb3 Antagonists for the Treatment of Pain
ResearchCo Investigator · Awarded by University of North Carolina - Chapel Hill · 2023 - 2025The role of pericytes in delirium superimposed on dementia.
ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2025Development of arrestin-biased dopamine D1 receptor (D1R) ligand for the treatment of Parkinson's disease with minimal L-DOPA induced dyskinesia
ResearchCo Investigator · Awarded by Michael J. Fox Foundation for Parkinson's Research · 2023 - 2024Bacteriophage virus-like particle vaccines for fentanyl and heroin overdose
ResearchCo Investigator · Awarded by University of New Mexico · 2021 - 2024Defining the role of peripheral Adrb3 in chronic pain and inflammation
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2024Evaluating cell type-specific non-dopaminergics as a Parkinson's treatment paradigm
ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2024Molecular and circuitry mechanism underlying autism behaviors in Shank3 mouse models
ResearchPrincipal Investigator · Awarded by Yale University · 2019 - 2023Exploiting Biased Agonism at the Ghrelin Receptor (GHSR 1a) for Opioid Addiction
FellowshipCo-Sponsor · Awarded by National Institutes of Health · 2022 - 2023Heat Shock Factors and Protein Misfolding Disease
ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2023DART2.0: comprehensive cell type-specific behavioral neuropharmacology
ResearchCollaborating Investigator · Awarded by National Institutes of Health · 2018 - 2022Exploiting Dopamine Receptor Functional Selectivity as an Approach to Treat Parkinson's Symptoms
ResearchCo Investigator · Awarded by National Institutes of Health · 2017 - 2022Phase 1 - Biased Agonists as Rapidly Acting Neuropsychiatric Drugs
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2020 - 2022Targeting microbially-derived juvenile protective factors to resolve neuroinflammation and delirium
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2022In Vivo Epigenome Editing with CRISPR-Based Histone Acetyltransferase Transgenic Mice
ResearchAssociate Research Professor · Awarded by National Institutes of Health · 2016 - 2022Bioelectronic rescue of cognitive impairment after surgery
ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2021Molecular and cellular control of injury-induced astrogenesis
ResearchCo Investigator · Awarded by National Institutes of Health · 2017 - 2021Novel Adjuvants and Carriers for Opiod Vaccines
ResearchCo Investigator · Awarded by National Institutes of Health · 2014 - 2020Developing a New Therapeutic Agent for Kabuki Syndrome
ResearchPrincipal Investigator · Awarded by Rescindo Therapeutics Inc · 2019 - 2020Akt/GSK-3 Signaling Cascade and the Actions of Dopamine
ResearchCo Investigator · Awarded by National Institutes of Health · 2005 - 2020Simultaneous and Bidirectional Chemogenetic Control of Mesolimbic and Nigrostriatal Circuits
ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2020Molecular, Synaptic, and Circuit Basis for Schizophrenia-related Phenotypes
ResearchCo Investigator · Awarded by National Institutes of Health · 2014 - 2020Developing a new therapeutic agent for Kabuki syndrome
ResearchCo Investigator · Awarded by Rescindo Therapeutics Inc · 2018 - 2019Molecular and circuitry mechanism underlying autism behaviors in Shank3 mouse models
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2019Cortico-striatal neurotransmission and compulsive motor behaviors
ResearchCo Investigator · Awarded by National Institutes of Health · 2008 - 2019Initial SHANK3 Study (Rugen E & F)
ResearchPrincipal Investigator · Awarded by Rugen Holdings (Cayman) · 2017 - 2019Initial SHANK3 Study
ResearchPrincipal Investigator · Awarded by Rugen Holdings (Cayman) · 2016 - 2019Linking Ciliary Biology to the Functional Annotation of Psychiatric Disorders
ResearchPrincipal Investigator · Awarded by University of Nevada - Las Vegas · 2018 - 2018Quantitative MR Microscopy of Phenotypic Biomarkers in Alzheimer's Disease
ResearchCo-Mentor · Awarded by National Institutes of Health · 2013 - 2018Analysis of Shank3 Complete and Temporal and Spatial Specific Knockout Mice
ResearchCollaborator · Awarded by National Institutes of Health · 2012 - 2018Receptor Regulation of CCK Cell Function
ResearchConsultant · Awarded by National Institutes of Health · 2013 - 2018IPA - Jiechun Zhou
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2018IPA - William Wetsel
ResearchAssociate Research Professor · Awarded by National Institutes of Health · 2017 - 2018Fragile X Phenotypes Modulated by Altered Signaling to the Synaptic Cytoskeleton
ResearchAssociate Research Professor · Awarded by National Institutes of Health · 2014 - 2018Linking ciliary biology to the functional annotation of psychiatric disorders
ResearchCo Investigator · Awarded by National Institutes of Health · 2016 - 2017Regulation of Cocaine Reward and Reinforcement by MeCP2
ResearchCo Investigator · Awarded by National Institutes of Health · 2013 - 2017Functional Selectivity: A Novel Approach for CNS Drug Discovery
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2012 - 2017STIM1-dependent calcium signaling in neuronal responses to hypoxia and ischemia
ResearchCollaborator · Awarded by National Institutes of Health · 2015 - 2017The 5-HT theory of depression tested in a naturalistic model of 5-HT deficiency
ResearchCo Investigator · Awarded by National Institutes of Health · 2006 - 2017Effect of two Rugen compounds on Novel Object Phobia in wild type (WT) and SAPAP3 KO mice
ResearchPrincipal Investigator · Awarded by Rugen Holdings (Cayman) · 2014 - 2017Optimizing Lead 5-HT2C Ligands for Use in the Treatment of Schizoprenia
ResearchPrincipal Investigator · Awarded by University of Illinois at Chicago · 2013 - 2015Novel high-throughput screening for modifiers of TorsinA pathology
ResearchCollaborator · Awarded by National Institutes of Health · 2013 - 2015Amphetamine-Induced Transcriptional Plasticity in Striatal GABAergic Interneurons
ResearchCo Investigator · Awarded by National Institutes of Health · 2012 - 2015Prevention of Temporal Lobe Epilepsy
ResearchCollaborator · Awarded by National Institutes of Health · 2012 - 2014Regulation of response to chronic antidepressant treatment by MeCP2
ResearchCo Investigator · Awarded by National Institutes of Health · 2012 - 2014Imaging NFkB Activity in Relation to Animal Behavior in Peripheral Neuropathy
FellowshipCollaborator · Awarded by National Institutes of Health · 2013 - 2014Novel Genetic Mouse Model to Study the Consequences of TorsinA Dysfunction
ResearchCo Investigator · Awarded by National Institutes of Health · 2011 - 2014Non-invasive Chemical Genetic Control of Neuronal Activity
ResearchCollaborator · Awarded by National Institutes of Health · 2009 - 2014Agilent Direct Drive 9.4T MRS/MRI Console
EquipmentMajor User · Awarded by National Institutes of Health · 2012 - 2013PTSD-like phenotype of mice lacking GIT2
ResearchInvestigator · Awarded by National Institutes of Health · 2010 - 2012Hormonal regulation of a Ca2+/AMPK signaling pathway
ResearchCollaborator · Awarded by National Institutes of Health · 1984 - 2011Epigenetic regulation of transcriptional repression by drugs of abuse
ResearchCo Investigator · Awarded by National Institutes of Health · 2006 - 2011Stress and Behavior in Health and Disease
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1989 - 2011Pharmacometabolomics Research Network
ResearchCo Investigator · Awarded by National Institutes of Health · 2010 - 2011Roles of SAPAP Proteins in Synaptic Function and Compulsive-like Behavior
ResearchCo Investigator · Awarded by National Institutes of Health · 2007 - 2010Cocaine Withdrawal: A Window of Treatment Opportunity
ResearchCo Investigator · Awarded by National Institutes of Health · 1999 - 2010Collaborative & Physiological Experiments to Breed CPE KO Mice
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2006 - 2007The Pathophysiology of CMT2A in Cell and Animal Models
ResearchCo Investigator · Awarded by National Institutes of Health · 2006 - 2007Collaborative & Physiological Experiments to Breed CPE KO Mice
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2005 - 2005Collaborative & Physiological Experiments
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2004 - 2005Genetic Rescue Of Pro-Lhrh Processing In Cpefat Mice
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1998 - 2004Collaborative & Physiological Experiments of CPE K/O Mice
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2003External Relationships
- DARPA
- National Institutes of Health
- National Institutes of Health -- Study Section for Psychedelics
- Onsero Therapeutics -- Company was bought, no longer associated with this company
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.